The estimated Net Worth of Jean Olivier Racine is at least $869 Тысяча dollars as of 10 May 2024. Mr Racine owns over 8,306 units of Outset Medical stock worth over $135,316 and over the last 3 years he sold OM stock worth over $192,697. In addition, he makes $540,928 as Chief Technology Officer at Outset Medical.
Mr has made over 12 trades of the Outset Medical stock since 2022, according to the Form 4 filled with the SEC. Most recently he sold 8,306 units of OM stock worth $27,161 on 10 May 2024.
The largest trade he's ever made was selling 8,306 units of Outset Medical stock on 10 May 2024 worth over $27,161. On average, Mr trades about 1,442 units every 46 days since 2021. As of 10 May 2024 he still owns at least 265,325 units of Outset Medical stock.
You can see the complete history of Mr Racine stock trades at the bottom of the page.
Jean-Olivier Racine is the Chief Technology Officer at Outset Medical.
As the Chief Technology Officer of Outset Medical, the total compensation of Mr Racine at Outset Medical is $540,928. There are 3 executives at Outset Medical getting paid more, with Leslie L. Trigg having the highest compensation of $875,082.
Mr Racine is 39, he's been the Chief Technology Officer of Outset Medical since . There are 9 older and no younger executives at Outset Medical. The oldest executive at Outset Medical, Inc. is Donald Siemens, 70, who is the Independent Director.
Over the last 4 years, insiders at Outset Medical have traded over $829,589,795 worth of Outset Medical stock and bought 42,000 units worth $1,172,030 . The most active insiders traders include Pincus Llc Warburg, Pincus X, L.P.Warburg Pincu... и Pincus X, L.P.Wp X Finance,.... On average, Outset Medical executives and independent directors trade stock every 7 days with the average trade being worth of $44,055. The most recent stock trade was executed by Leslie Trigg on 15 August 2024, trading 5,308 units of OM stock currently worth $4,459.
Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.
Outset Medical executives and other stock owners filed with the SEC include: